Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,898.34
-27.3540-1.42%
Number of Gainers:7
Number of Losers:12
Number of Flat:- -
PE:- -
High:1,922.48
Open:1,922.48
Low:1,894.89
Close:1,925.70
Volume:93.89M
Turnover:8.48B
Market Cap:1.55T
Float Cap:1.51T

Loading ...

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Moderna Inc. Stock Rallies 14.4%, Outperforms Peers

Dow Jones
·
Yesterday

Novavax Inc. Stock Rallies 6.5%, Outperforms Peers

Dow Jones
·
Yesterday

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Yesterday

Abbott Laboratories Gets Regulatory Authorization for Dual Glucose-Ketone Sensor

MT Newswires Live
·
Yesterday

FDA Authorizes Abbott's Wearable to Monitor Ketone and Glucose in Diabetes Patients

Reuters
·
Yesterday

Abbott receives FDA authorization for Libre Duo 10 Day system

TIPRANKS
·
Yesterday

Abbott - to Launch Libre Duo 10 Day in U.S. Later This Year

THOMSON REUTERS
·
Yesterday

Abbott Receives FDA Authorization for World's First Dual Glucose-Ketone Sensing Technology for People with Diabetes

THOMSON REUTERS
·
Yesterday

FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar

Reuters
·
Yesterday

FDA :Granted Marketing Authorization to Abbott Diabetes Care for Libre Duo 10 Day Through De Novo Premarket Review Pathway

THOMSON REUTERS
·
Yesterday

Moderna Shares Rise After Wolfe Research Upgrade

MT Newswires Live
·
Yesterday

Moderna Stock Gains as Melanoma Vaccine Results De-Risk Approach

Dow Jones
·
Yesterday

AstraZeneca Deepens Its Type 2 Diabetes Pipeline With New Global Patient Mapping Study

TIPRANKS
·
Yesterday

Moderna rises 13.0%

TIPRANKS
·
Yesterday

AstraZeneca Climbs Tuesday, Outperforms Market

Dow Jones
·
Yesterday

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
Yesterday

Moderately bullish activity in Moderna with shares up 11.44%

TIPRANKS
·
Aug 25

Moderna Raised to Peer Perform from Underperform by Wolfe Research

Dow Jones
·
Aug 25